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AbsTRACT
To update the European League Against Rheumatism 
(EULAR) recommendations for the role of the nurse 
in the management of chronic inflammatory arthritis 
(CIA) using the most up to date evidence. The EULAR 
standardised operating procedures were followed. A 
task force of rheumatologists, health professionals and 
patients, representing 17 European countries updated 
the recommendations, based on a systematic literature 
review and expert consensus. Higher level of evidence 
and new insights into nursing care for patients with 
CIA were added to the recommendation. Level of 
agreement was obtained by email voting. The search 
identified 2609 records, of which 51 (41 papers, 10 
abstracts), mostly on rheumatoid arthritis, were included. 
Based on consensus, the task force formulated three 
overarching principles and eight recommendations. 
One recommendation remained unchanged, six were 
reworded, two were merged and one was reformulated 
as an overarching principle. Two additional overarching 
principles were formulated. The overarching principles 
emphasise the nurse’s role as part of a healthcare team, 
describe the importance of providing evidence-based 
care and endorse shared decision-making in the nursing 
consultation with the patient. The recommendations 
cover the contribution of rheumatology nursing in 
needs-based patient education, satisfaction with care, 
timely access to care, disease management, efficiency 
of care, psychosocial support and the promotion of self-
management. The level of agreement among task force 
members was high (mean 9.7, range 9.6-10.0). The 
updated recommendations encompass three overarching 
principles and eight evidence-based and expert opinion-
based recommendations for the role of the nurse in the 
management of CIA.
InTRoduCTIon
In several European countries, rheumatology 
nursing has developed into a recognised specialty 
with nurses undertaking both advanced and 
extended roles.1–3 Rheumatology nurses operate 
telephone advice lines, provide self-management 
support, patient education and counselling.4–8 
Moreover, they participate in disease management, 
monitor disease-modifying treatments, give 
intra-articular injections, refer to other health 
professionals, prescribe drug treatments and help 
to manage comorbidities.2 9–12 In some European 
countries, such as the Netherlands, Denmark, 
Ireland and the United Kingdom (UK), nurse-led 
clinics are well established. These add value to 
patient outcomes and equal the cost of traditional 
physician-led follow-up.13–17
In 2012, the European League Against Rheu-
matism (EULAR) recommendations for the role 
of the nurse in the management of chronic inflam-
matory arthritis (CIA), confined to rheumatoid 
arthritis (RA), ankylosing spondylitis and psoriatic 
arthritis, or spondyloarthritis, were published.18 
The 10 recommendations have provided a basis for 
improved and more standardised levels of profes-
sional nursing care across Europe. Evaluation of 
these recommendations showed a high level of 
agreement across countries and regions, but large 
differences in application, suggesting that they are 
not widely implemented.19–21 Moreover, some of 
the recommendations were based on a low level 
of evidence.18 Since publication of the recommen-
dations, several studies on rheumatology nursing 
have been published, which contribute to increased 
insight and better evidence. The objective of this 
study was to review the literature from 2010 to date 
in order to update the EULAR recommendations 
for the role of the nurse in the management of CIA.
MeTHods
The updated version of the EULAR standardised 
operating procedures for EULAR-endorsed recom-
mendations was followed.22 These include a 
systematic literature review (SLR) and a task force 
(TF) meeting. A steering committee consisting 
of five members from the former TF appointed a 
TF representing 17 European countries, including 
two members from the EMerging EUlar NETwork 
(EMEUNET). The TF comprised 15 nurses, two 
patient research partners, one physiotherapist, 
one psychologist, one occupational therapist, one 
medical student and three rheumatologists, one of 
whom was also a methodologist.
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Table 1 2018 update of the EULAR recommendations for the role of the nurse in the management of CIA
overarching principles
Rheumatology nurses are part of a healthcare team
Rheumatology nurses provide evidence-based care
Rheumatology nursing is based on shared decision-making with the patient
Recommendations Level of evidence* Grade of recommendation* Level of agreement†
(0–10)
1 Patients should have access to a nurse for needs-based education 
to improve knowledge of CIA and its management throughout 
the course of their disease
1B A 10.0±0.2
[9-10]
2 Patients should have access to nurse consultations in order to 
enhance satisfaction with care
1A A 9.7±0.6
[8-10]
3 Patients should have the opportunity of timely access to a nurse 
for needs-based support; this includes tele-health
1B B 9.7±0.6
[8-10]
4 Nurses should participate in comprehensive disease management 
to control disease activity, reduce symptoms and improve patient-
preferred outcomes; this leads to cost-effective care
1A A 9.7±0.5
[8-10]
5 Nurses should address psychosocial issues to reduce patients’ 
symptoms of anxiety and depression
1B A 9.6±0.7
[8-10]




7 Nurses should have access to and undertake continuous 
education in the specialty of rheumatology to improve and 
maintain knowledge and skills
2C B 9.8±0.7
[7-10]
8 Nurses should be encouraged to undertake extended roles after 
specialised training and according to national regulations
1A A 9.7±0.6
[8-10]
*According to the Oxford Centre for Evidence-based Medicine - CEBM ‘Levels of Evidence 1’.
†Expert agreement achieved by all members of the Task Force upon the consensus meeting (data are mean ±SD, [range]).
CIA, chronic inflammatory arthritis.
The search strategy from the first recommendations was 
replicated for the period August 2010 until 1 December 2017. 
Abstracts from the American College of Rheumatology/the 
Association of Rheumatology Professionals and EULAR confer-
ences 2016 and 2017 were hand searched. The full search strat-
egies for each bibliographic database are provided in online 
supplementary text S1. A web-based software platform, Covi-
dence, was used to screen the titles, abstracts and full texts 
independently by the fellow (BB) and the convener (YvE-H).23 
The selection of titles and abstracts was shared with the TF to 
check for comprehensiveness before full text review. A detailed 
overview of the results from the SLR was sent to the TF before 
the consensus meeting. The steering committee discussed the 
results from the SLR and prepared a preliminary update of 
the recommendations before the TF meeting. Only studies 
providing evidence of higher level than the first recommenda-
tions and additional knowledge about rheumatology nursing, 
were considered. In the 1-day consensus meeting, the prelimi-
nary updated recommendations were presented to the TF one 
at a time with the corresponding new evidence. Consensus 
was achieved through voting and, if necessary, discussions to 
reach agreement on final wording.22 After the TF meeting, the 
evidence was categorised according to the Oxford Centre for 
Evidence-Based Medicine into four grades of recommenda-
tions from A (highest) to D (lowest) and five levels of evidence 
(1–5, high–low).24 Finally, the level of agreement for each of 
the updated recommendations was assessed by email using a 
0–10 numerical rating scale (0 = ‘do not agree at all’ and 10 
= ‘fully agree’). A quality assessment of papers that resulted 
in a higher level of evidence was performed by the steering 
committee. For critical appraisal, A MeaSurement Tool to 
Assess systematic Reviews (AMSTAR II), the Cochrane Risk of 
bias tool for randomised controlled trials (RCTs), the QUality 
In Prognosis Studies tool for observational studies (QUIPS) and 
the Consensus on Health Economic Criteria (CHEC) list for 
the included economic evaluations were used.25–28 The draft 
manuscript was reviewed by all TF members and approved by 
the EULAR executive committee.
ResuLTs
The SLR identified 2609 records, 51 of which were included in 
the full review (see online supplementary figure S2). The selected 
papers comprised two meta-analyses, nine RCTs (14 papers), 
18 observational studies (20 papers), eight surveys, two mixed-
method and five qualitative studies. The quality assessment of 
the studies that enhanced the level of evidence is presented in 
online supplementary text S3.
The TF achieved consensus on the final wording of the 
updated recommendations. Only one former recommendation 
remained unchanged; six recommendations were reworded; 
two were merged and one was reformulated as an overarching 
principle (online supplementary table S4). Two additional over-
arching principles were formulated, resulting in a total of eight 
recommendations and three overarching principles.
overarching principles
During the discussions, the TF identified certain themes consid-
ered to apply to all recommendations and agreed on three over-
arching principles (as presented in table 1):
1. Rheumatology nurses are part of a healthcare team
Rheumatology nurses do not work in isolation, but in close 
collaboration with the patient (and family/significant others, 
as appropriate), the rheumatologist and, if applicable, a wider 
healthcare team, with a common focus on care and outcome.29
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2.Rheumatology nurses provide evidence-based care
Rheumatology nursing is based on the principles of evidence-
based practice. Evidence-based care integrates different sources 
of knowledge in practice: (i) research evidence, (ii) clinical 
nursing experience, (iii) patients’ experiences, preferences and 
values and (iv) the local context.30 31 Providing evidence-based 
care is broader than care based on protocols and guidelines. To 
emphasise this breadth the task force decided to remove former 
recommendation No 7 (online supplementary table S4) and 
formulated this as an overarching principle.
3.Rheumatology nursing is based on shared decision-making with 
the patient
Patients’ values and preferences are part of the comprehen-
sive process of proper knowledge exchange and consensus on 
treatment decision.32 33 Although evidence-based practice also 
includes taking patients’ values and preferences into account, the 
TF wanted to emphasise this strongly.
updated recommendations
Table 1 also presents the recommendations, including the level of 
evidence, grade of recommendation and the level of agreement 
among TF members. Compared with the first recommenda-
tions, the level of evidence increased for five recommendations 
(online supplementary table S4). The level of evidence ranged 
from 1A to 2C and grade of recommendation ranged from A to 
B. The level of agreement within the TF was high for the indi-
vidual recommendations, ranging from 9.6 to 10 in this update, 
compared with 8.4 to 9.9 in the first recommendations (online 
supplementary table S4). The first three recommendations are 
formulated from the patients’ perspective, and the remaining 
five from the nurses’ perspective.
Recommendation 1: Patients should have access to a nurse 
for needs-based education to improve knowledge of CIA and its 
management throughout the course of their disease
Patient education covers a wide variety of educational activi-
ties including therapeutic and health education as well as health 
promotion.5 Besides improving knowledge and disease control, 
the goal is to enable patients to manage their life with a chronic 
disease.5 The updated SLR confirmed a high level of evidence 
for this recommendation.34–37 One RCT showed that the use 
of the Educational Needs Assessment Tool (ENAT) to identify 
and prioritise patients’ individual educational needs significantly 
increased the effect of patient education delivered by nurses.36 It 
was proposed to add ‘needs-based’ to the revised recommenda-
tion, which is also in accordance with the EULAR recommenda-
tions for patient education for people with CIA.5 There was some 
discussion by the TF as the term ‘needs-based’ might ignore the 
possibility that some patients may require information first to be 
able to determine their educational needs. The TF emphasised 
the importance of individualised patient education, and that 
there may be other ways of assessing patients’ individual educa-
tional needs than the ENAT. High level of evidence for improved 
self-management skills, increased self-efficacy and global well-
being in patients with RA confirmed the beneficial outcomes 
of patient education.34 36 37 These effects remained up to 1 and 
2 years when supported by subsequent outpatient nurse-led 
follow-up.7 8 Additional evidence from RCTs supported positive 
effects on pain, fatigue, illness perception, quality of life and 
sedentary time from nurse-led patient educational programmes 
and involvement of nurses in self-regulation coaching in a multi-
component, action-focused intervention.35 38 Moreover, cohort 
studies and one cross-sectional study presented the beneficial 
outcomes of nurse-led patient education, such as the develop-
ment of more and timely educational activities for patients, 
improving patients’ adherence to treatments.39–44
Recommendation 2: Patients should have access to nurse 
consultations in order to enhance satisfaction with care
Patients satisfaction can be an indicator of he quality of care.45 
Evidence from a meta-analysis showed a significant positive long-
term (2 years) effect of nurse consultations on patients’ satisfac-
tion.3 In a recent RCT, patients with RA were equally satisfied 
with tele-health follow-up delivered by nurses compared with 
rheumatologist delivered tele-health or conventional physi-
cian-led follow-up for tight control of disease activity.6 Given 
the strength of evidence for patient satisfaction the steering 
committee suggested prioritising satisfaction with care over 
‘continuity’ and ‘communication’ in the previous recommen-
dation. Additionally, four qualitative studies in RA outpatients 
reported positive experiences of the continuing relationship 
with the nurse that promoted a sense of confidence, familiarity, 
security and participation.46–49 Nurses’ holistic and professional 
approach to care, patients’ confidence in nurses’ competence, 
and a supportive, and less factual interaction style than consulta-
tions with physicians were emphasised.46–49 The TF interpreted 
this to be closely related to patients’ satisfaction.
Recommendation 3: Patients should have the opportunity of 
timely access to a nurse for needs-based support; this includes 
tele-health
The unpredictable, fluctuating nature of rheumatic and 
musculoskeletal diseases and expanded treatment options with 
increasing complexity of therapeutic strategies, such as “treat-to-
target” (T2T), require rapid and timely access to care.50 Nurses 
have an important role in the T2T principles. This was shown in 
two recent RCTs with nursing-staffed/managed helplines incor-
porated into different modes of follow-up care.6 8 37 The acces-
sibility to care, traditionally ensured by telephone helplines, 
provided a valuable clinical service as an adjunct to face-to-face 
consultation.51 In a qualitative study, patients expressed the view 
that this was linked to their feeling of confidence in access to 
personalised support from a competent healthcare team.47 The 
steering committee agreed that this recommendation should 
focus on timely access in general, rather than specific focus on 
telephone support lines, as timely access can also include other 
opportunities for support. Tele-health, defined as a generic term 
for remote delivery of healthcare by a range of options, including 
landline or mobile phones and the internet, enables accessibility 
and appropriate care and has provided new modes of commu-
nication with patients, and other opportunities for support and 
monitoring.52 Tele-health follow-up by nurses was found to be 
non-inferior to conventional physician-led follow-up for tight 
control of disease activity in RA.6 The TF added the wording 
‘tele-health’ to this recommendation also including telephone 
as a mode of support, and the established respect of telephone 
help-lines—for example, the hours allocated to operate them.
Recommendation 4: Nurses should participate in compre-
hensive disease management to control disease activity, reduce 
symptoms and improve patient-preferred outcomes; this leads to 
cost-effective care
With new treatment possibilities and available evidence, 
management of RA has become increasingly complex.50 53 The 
involvement of nurses as part of multidisciplinary team care 
is needed in a T2T strategy for proactive disease manage-
ment based on patient education, tight disease monitoring 
and adjustment of the pharmacological treatment.50 53 54 The 
level of evidence was high for this recommendation and it 
was further strengthened by two meta-analyses and one RCT 
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with long-term follow-up.3 8 37 55 These studies and additional 
RCTs that compared nurse-led and physician-led follow-up, and 
cohort studies, showed that nurse-led care resulted in equiva-
lent or improved control of disease activity in patients with 
RA.6 8 16 37 42 55 56 Nurse-led care was cost neutral or slightly less 
costly than physician-led care but no evidence for cost savings 
was found.14 16 57–59 Therefore, the TF decided to add cost-effec-
tiveness to recommendation No 4 and delete the former recom-
mendation No 10 on cost savings (online supplementary table 
S4).
For patient-preferred outcomes, there were no significant 
differences in fatigue, physical disability or quality of life between 
nurse-led and physician-led follow-up.3 Additional evidence 
from various studies supports the distinct role of the nurse for 
patients with RA. Nurses have an established role in joint exam-
ination, management of comorbidity screening, strengthening of 
adherence to vaccination regimens, early detection of arthritis, 
interpretation of laboratory results, and initiation and adjust-
ment of the pharmacological treatment.11 60–68
Recommendation 5: Nurses should address psychosocial issues 
to reduce patients’ symptoms of anxiety and depression
Psychological distress among people with arthritis has a signif-
icant negative effect on their physical well-being and needs to 
be acknowledged.69 Furthermore, depression is a well-known 
comorbidity and should be addressed.70 One RCT exam-
ined depression and found non-inferiority of nurse-led care 
compared with rheumatologist-led care.16 Qualitative studies 
emphasised that patients valued the opportunity to discuss the 
wider implications of their condition with a nurse.47–49 67 The 
TF perceived that addressing these needs includes assessment 
and identification of psychosocial problems, counselling and 
referral to other health professionals when needed, which are 
key components of nursing care, and described in one report of 
practice experience.71 The TF suggested adding the word ‘symp-
toms’ to change the recommendation into a more preventive 
approach to incorporate more than just an established diagnosis 
of anxiety or depression. As earlier reports support interventions 
to reduce anxiety and depression, the TF decided to replace the 
word ‘minimise’ in the previous recommendation with the word 
‘reduce’.72 73
Recommendation 6: Nurses should support self-management 
skills to increase patients’ self-efficacy
Self-efficacy is essential for patients to remain in charge of 
their life, despite the unpredictable course of their condition, and 
the concept is linked to the patient’s self-management skills.74 
Self-management support offers patients the opportunity to 
gain the necessary knowledge, skills and confidence to deal with 
physical and psychosocial consequences of living with a chronic 
condition and make preferred lifestyle changes.75 Supporting the 
patients’ self-management is a collaborative activity that expands 
the role of the healthcare team from delivering information and 
traditional patient education to include activities that support 
self-management.76 77 Higher level of evidence supported the 
statement that nurse-led interventions can improve patients’ 
self-efficacy.3 7 34 36 A long-term RCT comparing planned nursing 
consultations with shared care and physician-led follow-up in 
RA, showed significantly increased self-efficacy among patients 
in the nurse-led group after 2 years' follow-up.8 Evidence from 
RCTs also showed that nurse-led care improved patient activa-
tion, self-efficacy for physical activity and motivation, as well as 
patients’ self-assessment.7 11 34 35 A recent cohort study and several 
descriptive studies found that nurse-led interventions enhanced 
patients’ confidence in facilitating their daily life, behavioural 
change and coping with disease fluctuations.47–49 67 78–80 The 
TF discussed the terms ‘empowerment’ and ‘sense of control’, 
which were used in the former recommendation No 6 (online 
supplementary table S4). Because the SLR did not identify addi-
tional evidence for these concepts, the TF decided to confine this 
recommendation to self-efficacy, which increased the strength of 
this recommendation.
Recommendation 7: Nurses should have access to and under-
take continuous education in the specialty of rheumatology to 
improve and maintain knowledge and skills
The level of evidence for this recommendation increased owing 
to new evidence from cohort studies. Educational programmes 
for rheumatology nurses were associated with increased knowl-
edge, skills and improvement of practice.81–83 Some tasks, tradi-
tionally performed by rheumatologists and physiotherapists, 
such as joint examinations or musculoskeletal examinations, the 
identification of RA signs and symptoms and the ability to distin-
guish abnormalities, can be learnt by nurses through structured 
training.64–66 83 84 However, the SLR also revealed that some 
rheumatology nurses lacked understanding of the T2T strategy 
and confidence to perform examination of joints.85 Moreover, 
nurses lacked confidence to provide support for disease modi-
fying antirheumatic drugs, promote physical activity and deal 
with sexual concerns.86–89 The TF recognised a need for specific 
generic and rheumatology training. Rheumatology nursing is not 
a formal specialty in every country. To provide a workforce that 
can meet evolving needs in rheumatology clinics, global recog-
nition and development of this specialty is needed. Therefore, 
the wording ‘in the specialty of rheumatology’ was added to the 
recommendation. The TF discussed whether the formulation 
‘access to’ was necessary. In some countries however, there is no 
access to formal rheumatology education for nurses and the TF 
felt that access is crucial to develop this nursing capability.
Recommendation 8: Nurses should be encouraged to under-
take extended roles after specialised training and according to 
national regulations
The wording of this recommendation remained unchanged. 
However, the level of evidence increased based on two 
meta-analyses showing the effectiveness of nurse-led follow-up, 
which represents an advanced level.3 55 The TF discussed the 
definition of ‘basic nursing’ and ‘extended’ and ‘advanced’ prac-
tice roles. Three cross-sectional surveys described the breadth and 
complexity of rheumatology nursing, including prescribing and 
administering pharmacological treatments (oral, subcutaneous, 
intra-articular, intravenous), patient education and providing 
support for patients and their family/significant others.60 85 90 The 
TF agreed that extended and advanced practice roles comprise a 
broad spectrum of nursing activities determined by the complex 
needs of patients, from disease assessment, monitoring the impact 
of the disease and the effects of treatment to long-term support for 
self-management and prevention of complications.
Research agenda
Through discussions, the TF updated the research agenda 
(box 1), which reflects research topics to collect and strengthen 
the evidence for the value of the nurse in the management of 
CIA.
educational agenda
The educational agenda (box 2) supports educational opportuni-
ties as a prerequisite for quality in nursing care, and also specifies 
educational needs within all levels of nursing care and the need 
for the awareness of rheumatology as a medical specialty in the 
educational system.
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box 1 Research agenda
 ► To study the nursing contribution in improving access to care, 
using different modes of healthcare delivery
 ► To study the nursing contribution in facilitating the patients’ 
effective use of healthcare provided by members of the 
multidisciplinary team
 ► To study the nursing roles in optimising treat-to-target 
treatment strategies in patients with CIA
 ► To study the nursing contribution in improving patient-
preferred outcomes, including psychosocial issues, in both 
short- and long-term outcome studies
 ► To identify different components of nursing knowledge and 
competencies in each European country
 ► To study further the cost-effectiveness of nursing across 
different European countries.
 ► To study the nursing contribution to patients’ employment 
status and social participation
 ► To study the nursing contribution in the screening and 
management of risk factors and comorbidities
 ► To study further the nursing contribution to patient 
empowerment and self-efficacy
 ► To undertake implementation and evaluation studies of 
nursing interventions
 ► To provide the evidence for these nursing recommendations 
in patient populations with different rheumatic and 
musculoskeletal disease
 ► To study systematic ways to assess patients’ individual 
educational needs throughout the course of their disease
box 2 educational agenda
 ► To develop a competency framework for rheumatology 
nursing
 ► To develop rheumatology basic, advanced and extended level 
nursing education programmes
 ► To raise the profile of rheumatology nursing within 
undergraduate and postgraduate educational programmes
dIsCussIon
The EULAR recommendations for the role of the nurse in the 
management of CIA have been updated according to the current 
evidence. Three new overarching principles relevant for all eight 
recommendations were formulated. Different European studies 
have contributed to an increase in the level of the evidence and 
generalisability of the eight updated recommendations. This 
update represents even stronger consensus among the experts 
than the previous recommendations.
The SLR confirmed the contribution of rheumatology nurses to 
healthcare via tele-health, thus providing new opportunities for 
accessible and sustainable healthcare.6 91 Moreover, person-cen-
tred care and partnership with patients are important dimen-
sions, supporting a sense of confidence in nurse-led care.46–49 92
The broad scope of rheumatology nursing was also shown 
in a recent SLR.93 Outcomes from rheumatology nursing inter-
ventions in RA were found in multiple health domains, such as 
disease status, symptoms, physical and mental functioning, and 
patient safety. Furthermore, rheumatology nursing affects the 
quality of care in several dimensions. In another SLR, nurse-led 
care for patients with RA was shown to be highly acceptable, 
equally effective, efficient and safe compared with traditional 
physician-led care, and seemed appropriate and accessible from 
the patient’s perspective.94 However, extended roles should be 
responsive to patients’ needs therefore not abandoning nursing 
care, which is valued by patients. Good organisation of care is 
needed to avoid the risk of excessive workload which may lower 
the quality of care.
Following the publication of the first recommendations, 
rheumatology nursing has gained increased attention in several 
countries. In the TF for this update, we were able to include 
members from more countries across Europe in which rheuma-
tology nursing is now part of routine care. This is a strength 
of the process and will help to facilitate wider implementation 
of the updated recommendations. In contrast to the previous 
recommendations, we assessed the risk of bias of the studies that 
contributed to the new level of evidence. These were mainly of 
moderate to good quality, which strengthens our results.
There are limitations we need to address. Most study popu-
lations were outpatients with established RA and low disease 
activity. It is unknown if the results can be transferred to patients 
with early RA and to patients with other inflammatory rheumatic 
diseases, who have a higher risk of structural damage. Therefore, 
the updated recommendations should still be regarded as points 
to consider for these patients. In addition, costs and measures of 
health-related quality of life vary across countries and healthcare 
systems, and this may hamper transferability.95 96
Studies reporting nursing interventions that focus on healthy 
lifestyle and work participation were rare. The research agenda 
aims to examine these areas. Furthermore, we excluded studies 
where effects of nurse interventions could not be isolated from 
those of a multidisciplinary team. This reflects the current prac-
tice where nurses play an important, yet sometimes not clearly 
visible and distinguishable, role as part of multidisciplinary teams. 
Differences in the available skill mix in rheumatology teams in 
different countries or regions can determine who does what, 
and this may affect the quality of care received.97 Increasingly 
the importance of nurses’ communication skills for supporting 
patients in treatment decisions—for example, switching to 
biosimilars, is recognised.98 99 However, literature on this topic 
is still lacking. Finally, in the included RCTs, the definition of 
‘nurse-led care’ varied. In the UK, nurse-led care was defined as 
a practice model in which nurses provide education, monitoring 
and support for a certain group of patients, in collaboration with 
physicians and other members of multidisciplinary teams such 
as physiotherapists, occupational therapists and psychologists.15 
This definition was not recognisable in all the included studies 
where the competence of the nurse was most often explained by 
their title only. Therefore, the minimum competences (eg, the 
required education or skills needed for rheumatology nurses) to 
achieve similar results are unknown.
To date, standardised education and training for rheuma-
tology nurses is not available in every European country. The 
educational agenda aims to support access to well-defined 
basic, extended, and advanced practice level nursing education. 
Besides, sufficient training and supervision are required when 
undertaking extended and advanced practice roles. Education 
should reflect the complexity of tasks and activities performed 
by nurses.100 Moreover, the level of competences should be 
aligned across Europe. The current EULAR online educational 
course can address knowledge of rheumatic and musculoskeletal 
diseases, but it does not address all educational needs of nurses 
undertaking extended and advanced practice roles. Furthermore, 
the English language can be a barrier to many European nurses 
and therefore translation of the online education into several 
languages may be necessary.101
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The previous recommendations were translated into several 
languages and efforts were made to implement them in different 
countries.19 Similar initiatives to implement these updated recom-
mendations are important and need national and international 
support from stakeholders such as EULAR. Moreover, recommen-
dations that focus on a broader range of rheumatic and musculoskel-
etal diseases are needed. This may be considered in future updates.
In conclusion, this update of the 2012 EULAR recommendations 
for the role of the nurse resulted in three overarching principles and 
eight recommendations. The updated recommendations can further 
emphasise and optimise rheumatology nursing and contribute to 
more standardised levels of professional nursing across Europe.
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